Adcare Health Systems Inc RHEP
1.04
(0.02)
(1.89%)
as of 25 Sep
- Market cap
- $5.2M
- P/E
- 0.6×
Follow RHEP
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 2.56 | 1.08 | 0.67 |
P/S ratio |
0.15 | 0.07 | 0.07 | 0.05 | |
P/FCF ratio |
0.00 | 0.52 | 0.90 | 0.71 | |
P/Operating CF |
(3.20) | (2.84) | (5.48) | 3.12 | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.60 | 0.79 | 0.67 | 0.53 | |
EV/EBITDA |
54.80 | 10.79 | 11.74 | 9.63 | |
EV/Operating CF |
(1,482.24) | (18.63) | (13.27) | (16.78) | |
EV/FCF |
(77.52) | 6.13 | 8.26 | 7.12 | |
Quick Ratio |
0.63 | 0.52 | 0.50 | 0.52 | |
Current Ratio |
1.35 | 0.67 | 0.64 | 0.65 | |
Net Debt/EBITDA |
(1,537.45) | 9.84 | 1,082.57 | 70.00 | |
Debt/Assets |
67.33% | 63.64% | 63.35% | 62.62% | |
Debt/Equity |
(31.59) | 8.56 | (44.30) | 14.29 | |
Asset Turnover |
0.58 | 0.83 | 1.06 | 1.27 | |
Operating CF/Net income |
(0.49) | (0.47) | 0.77 | (1.77) | |
Capex/Depreciation |
(0.50) | 11.79 | (0.49) | (0.65) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
24.53% | 17.66% | 30.81% | 27.40% | |
Intangible Assets out of Total Assets |
0.08 | 0.09 | 0.09 | 0.09 | |
Share Based Compensation of Revenue |
0.82% | 0.30% | 0.45% | 0.30% | |
Graham Net Nets |
(8.42) | (12.95) | (10.66) | (10.94) | |
Graham Number |
9.80 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(41.30%) | 39.06% | 92.74% | 148.18% | |
Free Cash Flow Yield |
(13.63%) | 191.26% | 111.53% | 140.18% | |
Revenue per Share |
4.84 | 7.41 | 5.38 | 6.22 | |
Operating CF per Share |
(0.58) | (0.45) | (0.23) | 0.35 | |
Capex per Share |
(0.09) | 3.48 | (0.09) | (0.13) | |
Free Cash Flow per Share |
(0.67) | 3.03 | (0.32) | 0.23 | |
Cash per Share |
1.28 | 1.66 | 0.65 | 0.96 | |
Shareholders Equity per Share |
(0.49) | 1.80 | (0.24) | 0.76 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(0.49) | 1.80 | (0.24) | 0.76 | |
Free Cash Flow |
(2.08) | 8.50 | (1.25) | 0.89 | |
Working Capital |
6.57 | (7.87) | (9.03) | (9.37) | |
Capital Expenditures |
(0.28) | 9.77 | (0.36) | (0.50) | |
Net Current Asset Value |
(48.41) | (46.48) | (52.02) | (47.26) | |
EV/EBIT |
0.00 | 25.30 | 35.11 | 27.42 | |
Capex to Sales |
0.02 | (0.47) | 0.02 | 0.02 | |
Net Profit Margin |
24.18% | 12.99% | (5.47%) | (3.20%) | |
Price to Operating Income |
0.00 | 2.16 | 3.81 | 2.75 | |
| Other line items | |||||
Average Receivables |
4.87 | 5.69 | 6.85 | 7.33 | |
Average Payables |
5.82 | 5.34 | 9.12 | 7.21 | |
Average Assets |
66.11 | 64.14 | 63.28 | 64.05 | |
Average Common Equity |
(19.47) | (18.20) | (19.35) | (20.36) |
Columns are period end dates